Dr. Kamat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2001 - 2003
West Virginia UniversityChief Residency, Urology, 2000 - 2001- West Virginia UniversityResidency, Urology, 1997 - 2000
- West Virginia UniversityResidency, Surgery, 1995 - 1997
Seth G.S. Medical CollegeClass of 1994
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2002 - 2026
WA State Medical License 2023 - 2026
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025- American Board of Urology Urology
- Join now to see all
Awards, Honors, & Recognition
- Compassionate Doctor Award
- Top Doctors in America
- Who's Who in Medicine
- Join now to see all
Clinical Trials
- Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium Start of enrollment: 2003 Dec 01
- Markers of Response to Intravesical Bladder Cancer Therapy Start of enrollment: 2005 Jun 01
Publications & Presentations
PubMed
- 3 citationsRe: Thomas Powles, Begoña Pérez-Valderrama, Shilpa Gupta, et al. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. N Engl J Med 2024;390:87...Enrique Grande, Alison Jane Birtle, Ashish M Kamat
European Urology. 2024-12-01 - Reply to Christopher Guske, Seyed Behzad Jazayeri, and Roger Li's Letter to the Editor re: Amanda A. Myers, Wei Shen Tan, Valentina Grajales, et al. Challenging the Pa...Amanda A Myers, Ashish M Kamat
European Urology. 2024-12-01 - 2 citationsNovel Delivery Systems and Pharmacotherapeutic Approaches for the Treatment of Non-muscle-invasive Bladder Cancer.Félix Guerrero-Ramos, Joost L Boormans, Siamak Daneshmand, Paolo Gontero, Ashish M Kamat
European Urology Oncology. 2024-12-01
Journal Articles
- Seminars Article New Horizons in Bladder Cancer ResearchStephen B Williams, Ashish M Kamat, ScienceDirect
- Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer—ReplyAshish M Kamat, Stephen B Williams, JAMA
- Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018Ashish M Kamat, Yair Lotan, European Urology
- Join now to see all
Authored Content
- Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018September 2018
- Recommendations for Follow-up of Muscle-Invasive Bladder Cancer Patients: A Consensus by the International Bladder Cancer NetworkFebruary 2018
- Contribution of Bladder Cancer Pathology Assessment in Planning Clinical TrialsFebruary 2018
Press Mentions
Bladder Cancer Trial Finds Extended Lymph Node Surgery Doesn’t Improve SurvivalNovember 6th, 2024- Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday PodcastMay 17th, 2024
- Clinical Trials for Bladder CancerSeptember 3rd, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
